- Home
- ALXO vs ZENA Comparison
ALXO vs ZENA Comparison
Compare ALXO & ZENA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALXO
- ZENA
- Stock Information
- Founded
- ALXO 2015
- ZENA 2017
- Country
- ALXO United States
- ZENA Canada
- Employees
- ALXO N/A
- ZENA N/A
- Industry
- ALXO Biotechnology: Pharmaceutical Preparations
- ZENA
- Sector
- ALXO Health Care
- ZENA
- Exchange
- ALXO Nasdaq
- ZENA NYSE
- Market Cap
- ALXO 76.5M
- ZENA 82.4M
- IPO Year
- ALXO 2020
- ZENA N/A
- Fundamental
- Price
- ALXO $0.55
- ZENA $2.20
- Analyst Decision
- ALXO Strong Buy
- ZENA
- Analyst Count
- ALXO 6
- ZENA 0
- Target Price
- ALXO $4.14
- ZENA N/A
- AVG Volume (30 Days)
- ALXO 529.8K
- ZENA 174.4K
- Earning Date
- ALXO 05-08-2025
- ZENA 01-01-0001
- Dividend Yield
- ALXO N/A
- ZENA N/A
- EPS Growth
- ALXO N/A
- ZENA N/A
- EPS
- ALXO N/A
- ZENA N/A
- Revenue
- ALXO N/A
- ZENA $1,364,714.00
- Revenue This Year
- ALXO N/A
- ZENA N/A
- Revenue Next Year
- ALXO N/A
- ZENA N/A
- P/E Ratio
- ALXO N/A
- ZENA N/A
- Revenue Growth
- ALXO N/A
- ZENA 7.43
- 52 Week Low
- ALXO $0.46
- ZENA $1.41
- 52 Week High
- ALXO $17.83
- ZENA $12.43
- Technical
- Relative Strength Index (RSI)
- ALXO 37.26
- ZENA N/A
- Support Level
- ALXO $0.46
- ZENA N/A
- Resistance Level
- ALXO $0.63
- ZENA N/A
- Average True Range (ATR)
- ALXO 0.06
- ZENA 0.00
- MACD
- ALXO 0.02
- ZENA 0.00
- Stochastic Oscillator
- ALXO 42.86
- ZENA 0.00
About ALXO ALX Oncology Holdings Inc.
ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.
About ZENA ZENATECH INC
ZenaTech Inc is a enterprise software technology company that specializes in mission-critical cloud-based applications integrated with smart hardware to deliver innovative solutions across diverse industries. The Company operates in software development technology, sales, and distribution. The Company is also developing a drone manufacturing, sales, and distribution business. The company operates in two segments which is software development technology, sales, and distribution, as well as drone manufacturing, sales, and distribution.